Compare BHVN & BL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHVN | BL |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2022 | 2016 |
| Metric | BHVN | BL |
|---|---|---|
| Price | $14.34 | $31.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $29.08 | ★ $56.62 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | ★ $177,031,000.00 |
| Revenue This Year | N/A | $12.62 |
| Revenue Next Year | N/A | $10.90 |
| P/E Ratio | ★ N/A | $79.95 |
| Revenue Growth | N/A | ★ 43.78 |
| 52 Week Low | $7.48 | $24.70 |
| 52 Week High | $18.57 | $59.57 |
| Indicator | BHVN | BL |
|---|---|---|
| Relative Strength Index (RSI) | 48.79 | 55.05 |
| Support Level | $13.84 | $27.74 |
| Resistance Level | $15.04 | $34.09 |
| Average True Range (ATR) | 0.66 | 1.35 |
| MACD | -0.06 | 0.14 |
| Stochastic Oscillator | 42.13 | 79.72 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
BlackLine Inc is engaged in providing financial accounting close solutions delivered as Software as a Service (SaaS). The Company's solutions enable its customers to address various aspects of their critical processes, including financial close & consolidation, intercompany accounting, and invoice-to-cash. The majority of the revenue of the company is earned in the United States.